Development and characterization of a rat brain metastatic tumor model by multiparametric magnetic resonance imaging and histomorphology
Authors:
- Shuncong WangShuncong Wang
- Lei ChenLei Chen
- Yuanbo FengYFYuanbo Feng
- Ting YinTYTing Yin
- Jie YuJYJie Yu
- Frederik De KeyzerFKFrederik De Keyzer
- Ronald PeetersRPRonald Peeters
- Chantal Van OngevalCOChantal Van Ongeval
- Guy BormansGBGuy Bormans
- Johan SwinnenJSJohan Swinnen
- Jeroen SoeteJSJeroen Soete
- Martine WeversMWMartine Wevers
- 26 February 2022
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 39 (3) , 479-493
Abstract
To facilitate the development of new brain metastasis (BM) treatment, an easy-to-use and clinically relevant animal model with imaging platform is needed. Rhabdomyosarcoma BM was induced in WAG/Rij rats. Post-implantation surveillance and characterizations were systematically performed with multiparametric MRI including 3D T1 and T2 weighted imaging, diffusion-weighted imaging (DWI), T1 and T2 mapping, and perfusion-weighted imaging (PWI), which were validated by postmortem digital radiography (DR), µCT angiography and histopathology. The translational potential was exemplified by the application of a vascular disrupting agent (VDA). BM was successfully induced in most rats of both genders (18/20). Multiparametric MRI revealed significantly higher T2 value, pre-contrast-enhanced (preCE) T1 value, DWI-derived apparent diffusion coefficient (ADC) and CE ratio, but a lower post-contrast-enhanced (postCE) T1 value in BM lesions than in adjacent brain (p < 0.01). PWI showed the dynamic and higher contrast agent uptake in the BM compared with the adjacent brain. DR, µCT and histopathology characterized the BM as hypervascular tumors. After VDA treatment, the BM showed drug-related perfusion changes and partial necrosis as evidenced by anatomical, functional MRI parameters and postmortem findings. The present BM model and imaging modalities represent a feasible and translational platform for developing BM-targeting therapeutics.Keywords
This publication has 36 references indexed in Scilit:
- Sequential Systemic Administrations of Combretastatin A4 Phosphate and Radioiodinated Hypericin Exert Synergistic Targeted Theranostic Effects with Prolonged Survival on SCID Mice Carrying Bifocal Tumor XenograftsTheranostics, 2013
- Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brainBreast Cancer Research, 2012
- Delayed Contrast Enhancement on MR Images of Myocardium: Past, Present, FutureRadiology, 2011
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011
- A Dual-targeting Anticancer Approach: Soil and Seed PrincipleRadiology, 2011
- A Perspective on Cancer Cell MetastasisScience, 2011
- Correlation between the MR T2 value at 4.7 T and relative water content in articular cartilage in experimental osteoarthritis induced by ACL transectionOsteoarthritis and Cartilage, 2009
- Comparison of model‐based arterial input functions for dynamic contrast‐enhanced MRI in tumor bearing ratsMagnetic Resonance in Medicine, 2009
- Bevacizumab Plus Irinotecan in Recurrent Glioblastoma MultiformeJournal of Clinical Oncology, 2007
- User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliabilityNeuroImage, 2006